Venous Insufficiency and Neuromuscular Stimulation
VeINS
2 other identifiers
interventional
40
1 country
1
Brief Summary
The investigators will be evaluating the immediate and longer term effect of treatment with a medical device on the symptoms of chronic venous disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 12, 2014
CompletedFirst Posted
Study publicly available on registry
May 13, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedResults Posted
Study results publicly available
October 11, 2019
CompletedOctober 25, 2019
October 1, 2019
11 months
May 12, 2014
September 18, 2019
October 11, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage Change of Haemodynamic Flow
Doppler ultrasound measurements of femoral venous blood flow. The volume flow rate in blood vessel can be calculated by multiplying the cross-sectional area of the blood vessel by the mean velocity of the blood within it.
baseline, 20 minutes
Secondary Outcomes (2)
Improvement in Venous Symptoms
6 weeks
Leg Volume
6 weeks
Study Arms (4)
Healthy subjects
ACTIVE COMPARATORHealthy subjects, free from vascular disease
Superficial venous insufficiency
EXPERIMENTALClinically symptomatic and ultrasound evidence of superficial venous insufficiency
Deep venous insufficiency
EXPERIMENTALClinically symptomatic and ultrasound evidence of deep venous insufficiency
Deep venous obstruction
EXPERIMENTALClinically symptomatic and ultrasound evidence of deep venous obstruction
Interventions
Small transcutaneous electrical stimulator. Manufactured in UK by Firstkind UK Ltd, and licensed for use in humans
Eligibility Criteria
You may not qualify if:
- Group 2
- Group 3
- Group 4
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Charing Cross Hospital
Hammersmith, London, W6 8RF, United Kingdom
Related Publications (1)
Williams KJ, Moore HM, Ellis M, Davies AH. Pilot Trial of Neuromuscular Stimulation in Human Subjects with Chronic Venous Disease. Vasc Health Risk Manag. 2021 Dec 1;17:771-778. doi: 10.2147/VHRM.S320883. eCollection 2021.
PMID: 34880620DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Miss Kate Williams
- Organization
- Imperial College London
Study Officials
- PRINCIPAL INVESTIGATOR
Alun Davies
Imperial College London
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 12, 2014
First Posted
May 13, 2014
Study Start
August 1, 2013
Primary Completion
July 1, 2014
Study Completion
July 1, 2014
Last Updated
October 25, 2019
Results First Posted
October 11, 2019
Record last verified: 2019-10
Data Sharing
- IPD Sharing
- Will not share